A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2002
12/05/2002	WO2002096927A2 Ribozyme based treatment of female reproductive diseases
12/05/2002	WO2002096926A1 Modulators of pharmacological agents
12/05/2002	WO2002096922A1 An arylation method for the functionalization of o-allyl erythromycin derivatives
12/05/2002	WO2002096912A1 Novel ligand for nicotinic acetylcholine receptors useful in therapy
12/05/2002	WO2002096911A1 Novel heteroaryl-diazabicyclo-alkanes as cns-modulators
12/05/2002	WO2002096910A1 Cytotoxins, prodrugs, linkers and stabilizers useful therefor
12/05/2002	WO2002096909A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl) -methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors
12/05/2002	WO2002096907A1 Bicyclic nitrogen-containing heterocyclic derivatives for use as antibacterials
12/05/2002	WO2002096906A1 Aryl-8-azabicyclo[3.2.1]octanes for the treatment of depression
12/05/2002	WO2002096905A1 Thiazole compounds useful as inhibitors of protein kinases
12/05/2002	WO2002096903A2 Chemical derivatives and the use thereof as an anti-telomerase agent
12/05/2002	WO2002096896A1 Biologically active methylene blue derivatives
12/05/2002	WO2002096895A1 Oxazol/ thiazol-derivatives activators of the hppar-alpha receptor
12/05/2002	WO2002096894A1 Thiazole or oxazole derivatives which are useful in the treatment of cardiovascular and related diseases
12/05/2002	WO2002096893A1 Process for preparing a thialzole ppar-ligand and polymorphs thereof
12/05/2002	WO2002096888A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
12/05/2002	WO2002096887A1 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
12/05/2002	WO2002096886A1 Pyrimidine derivatives
12/05/2002	WO2002096885A1 Pyrimidine derivatives useful as selective cox-2 inhibitors
12/05/2002	WO2002096883A1 Tricyclic compounds useful as angiotensin ii agonists
12/05/2002	WO2002096879A1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
12/05/2002	WO2002096877A1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis
12/05/2002	WO2002096876A1 Carbamate and oxamide compounds as inhibitors of cytokine production
12/05/2002	WO2002096870A2 Sponge-derived terpenoids and methods of use
12/05/2002	WO2002096867A2 Inhibitors of protein kinase for the treatment of disease
12/05/2002	WO2002096866A2 Thiolalkyl benzoic acid derivatives
12/05/2002	WO2002096864A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
12/05/2002	WO2002096863A1 New phenylalkyloxy-phenyl derivatives
12/05/2002	WO2002096858A1 Cinnamide derivatives as kcnq potassium channel modulators
12/05/2002	WO2002096857A1 Novel retinoid derivatives and methods for producing said compounds and an anti-cancer pharmaceutical composition comprising said compounds
12/05/2002	WO2002096855A2 Anticholinergic compounds and methods of use
12/05/2002	WO2002096516A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
12/05/2002	WO2002096467A2 Pharmaceutical use for secreted bacterial effector proteins
12/05/2002	WO2002096466A1 Medicinal composition
12/05/2002	WO2002096465A1 Medicinal compositions for percutaneous absorption
12/05/2002	WO2002096463A1 A pde 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases
12/05/2002	WO2002096462A1 An adenosine a2a receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases
12/05/2002	WO2002096458A1 Anti-ngf antibodies for the treatment of various disorders
12/05/2002	WO2002096456A1 Use of il-18 inhibitors for treating or preventing cns injuries
12/05/2002	WO2002096453A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3 [4-(2- {4-methane sulfonyl oxyphenyl} ethoxy)phenyl] propanoic acid or 3-{4-[2- (4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl}-(s)-2-ethoxy propanoic acid and insulin
12/05/2002	WO2002096449A1 Carbohydrate modifying agent and drinks containing the modifying agent
12/05/2002	WO2002096445A2 Food compositions for reducing insulin resistance
12/05/2002	WO2002096438A1 Synergistic antibiotic compositions
12/05/2002	WO2002096436A1 The use of a compound with a negatively charged domain of radicals for the treatment of restenosis
12/05/2002	WO2002096435A2 Skin-permeable composition comprising a selective cyclooxygenase-2 inhibitor a monohydric alcohol
12/05/2002	WO2002096434A1 Plaster preparation
12/05/2002	WO2002096433A1 Methods for treating delirium using glucocorticoid receptor-specific antagonists
12/05/2002	WO2002096432A2 Hypotensive lipid (prostaglandin derivatives) and timolol compositions and methods of using same
12/05/2002	WO2002096431A1 Optically active compounds clearing malformed proteins
12/05/2002	WO2002096429A1 Agent for external therapy of psoriasis and method for producing said agent
12/05/2002	WO2002096428A1 Pharmaceutical combinations
12/05/2002	WO2002096427A1 Pyrimidine derivatives as selective inhibitors of cox-2
12/05/2002	WO2002096426A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
12/05/2002	WO2002096425A1 Utilization of bicyclic heterocycles for the treatment and prevention of arterial thrombotic diseases
12/05/2002	WO2002096424A1 Hetereocyclic beta-aminoacids and their use as anti-epileptogenic agents
12/05/2002	WO2002096423A2 Combination of a pde4 inhibitor and tiotropium or derivate thereof for treating obstructive airways
12/05/2002	WO2002096422A2 Combination of a dopamine d2-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways
12/05/2002	WO2002096421A1 5-substituted-2-arylpyridines as crf1 modulators
12/05/2002	WO2002096420A2 Method for treating nerve injury caused by surgery
12/05/2002	WO2002096419A1 Pharmaceutical composition comprising a tricyclic compound for the prevention or treatment of skin diseases
12/05/2002	WO2002096418A1 Pirenzepine ophthalmic gel
12/05/2002	WO2002096416A1 Store operated calcium influx inhibitors and methods of use
12/05/2002	WO2002096415A2 Use of azetidinone substituted derivatives in the treatment of alzheimer's disease
12/05/2002	WO2002096414A1 Medicament containing an effector of the glutathione metabolism together with alpha-lipoic acid for use in kidney replacement therapy
12/05/2002	WO2002096413A1 Composition comprising demethylcantharidin in combination with platinum-containing anticancer agents and use thereof
12/05/2002	WO2002096412A1 Ptpase inhibitors and method of using same
12/05/2002	WO2002096411A1 Use of an alkanoyl l-carnitine for the preparation of a medication to treat anhedonia
12/05/2002	WO2002096410A1 Use of the acetyl l-carnitine in association with the biotin for the treatment of patients with type 2 insulin-resistant diabetes mellitus
12/05/2002	WO2002096409A1 Use of acetyl l-carnitine for the preparation of a medication for the preventive therapy for pain
12/05/2002	WO2002096408A1 Coenzyme q and eicosapentaenoic acid (epa)
12/05/2002	WO2002096407A1 Liquid drug preparations
12/05/2002	WO2002096406A1 Medicinal compositions
12/05/2002	WO2002096405A1 Drug preparations
12/05/2002	WO2002096404A1 Method of treating gastroesophageal reflux disease and nocturnal acid breakthrough
12/05/2002	WO2002096403A1 Composition containing 2-aminophenylacetic acid
12/05/2002	WO2002096402A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3- [4-(2- {4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2- (4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl} -(s)-2-ethoxy propanoic acid and a biguanide drug
12/05/2002	WO2002096401A1 Solid pharmaceutical formulations comprising modafinil
12/05/2002	WO2002096400A1 Medicament which can be used for the treatment of cancer
12/05/2002	WO2002096399A1 Lipolysis accelerator, cosmetic skin preparation for body weight reduction and food or beverage composition each containing the same, and method for reducing body weight and medicinal use each based on activity of the same
12/05/2002	WO2002096398A2 Medicament containing an effector of the glutathione metabolism together with $g(a)-lipoic acid for treating diabetes mellitus
12/05/2002	WO2002096397A1 Bicyclic aromatic chemokine receptor ligands
12/05/2002	WO2002096395A1 Soft elastic capsules comprising ritonavir and/or lopinavir
12/05/2002	WO2002096393A1 Anorexic composition comprising calcium acetate
12/05/2002	WO2002096392A1 Taste-masking of highly water-soluble drugs
12/05/2002	WO2002096374A2 Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
12/05/2002	WO2002096368A2 Encapsulation of nanosuspensions in liposomes and microspheres
12/05/2002	WO2002096366A2 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
12/05/2002	WO2002096363A2 Method for treating fibrotic diseases or other indications
12/05/2002	WO2002096362A2 Method for treating fibrotic diseases or other indications vi
12/05/2002	WO2002096360A2 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals
12/05/2002	WO2002096358A2 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method
12/05/2002	WO2002096357A2 Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method
12/05/2002	WO2002096354A2 Enhancement of oral bioavailability of non-emulsified formulation of prodrug esters with lecithin
12/05/2002	WO2002096351A2 Ultrashort-acting opioids for transdermal application
12/05/2002	WO2002096348A2 Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment
12/05/2002	WO2002096318A2 Method for treating glaucoma v
12/05/2002	WO2002096317A2 Method for treating glaucoma vi
12/05/2002	WO2002096224A1 Oral composition comprising an extract from the bark of albizzia myriophylla
12/05/2002	WO2002096216A1 A method of improving the growth performance of an animal
12/05/2002	WO2002096202A1 Antibacterial composition containing an organic acid and copper salt

1 ... 5628 5629 5630 5631 5632 5633 5634 5635 5636 5637 5638 5639 5640 5641 5642 5643 5644 5645 5646 5647 5648 ... 7860